JMIR Formative Res: Supporting the Primary Outcomes of the Mirai Trial for the Adjunctive Digital Therapeutic Rejoyn (CT-152) in the Treatment of Major Depressive Disorder: Meaningful Change Analysis in the… #MentalHealth #DigitalTherapeutics #DepressionTreatment #Telemedicine #ClinicalTrials
New phase 2 trial data: Teclistamab-based induction therapy achieves deep remissions in transplant-eligible newly diagnosed multiple myeloma… #BCMA #Bispecificantibodies #Cancerimmunotherapy #Clinicaltrials #Haematology #BCMA #Bispecificantibodies #Cancerimmunotherapy #Clinicaltrials #Haematolo…
